Citius Pharmaceuticals, Inc.: Burning Cash Before Commercialization
skodonnell/iStock via Getty Images
Citius Pharmaceuticals (NASDAQ: CTXR) has received bullish market sentiments with investors looking at a possible robust pipeline development to support long-term growth. The two products that stand out in this company…
